Overview

Efficacy and Safety Stress Urinary Incontinence Study

Status:
Completed
Trial end date:
2005-02-01
Target enrollment:
Participant gender:
Summary
Study F1J-MC-SBBT will examine the effect of duloxetine treatment in women with SUI. The inclusion and exclusion criteria of this Phase 3 study will ensure that all subjects have a clinical diagnosis of SUI.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Duloxetine Hydrochloride